SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 41 filers reported holding INMUNE BIO INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of INMUNE BIO INC
ValueSharesWeighting
Q4 2021$127,000
-62.0%
12,473
-27.5%
0.00%
-50.0%
Q3 2021$334,000
+106.2%
17,200
+25.9%
0.01%
+100.0%
Q1 2021$162,000
-30.5%
13,663
+1.0%
0.00%
-25.0%
Q4 2020$233,000
-14.0%
13,534
-48.5%
0.00%
-50.0%
Q3 2020$271,00026,3000.01%
Other shareholders
INMUNE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Westside Investment Management, Inc. 37,105$239,7030.07%
QUADRANT CAPITAL GROUP LLC 60,000$387,6000.04%
Janney Montgomery Scott LLC 239,448$1,5470.01%
Financial Advocates Investment Management 11,500$74,2900.01%
MAI Capital Management 19,643$126,8940.00%
VALLEY NATIONAL ADVISERS INC 1,000$80.00%
NORTHERN TRUST CORP 20,297$131,1190.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 9,036$58,3730.00%
GEODE CAPITAL MANAGEMENT, LLC 143,657$928,0240.00%
View complete list of INMUNE BIO INC shareholders